Cargando…
Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma
Lung adenocarcinoma has entered into an era of immunotherapy with the development of immune checkpoint inhibitors (ICIs). The identification of immune subtype is crucial to prolonging survival in patients. The tumor microenvironment (TME) and metabolism have a profound impact on prognosis and therap...
Autores principales: | Li, Chang, Tian, Chen, Liu, Yangyang, Liang, Jinyan, Zeng, Yulan, Yang, Qifan, Liu, Yuting, Wu, Di, Wu, Jingjing, Wang, Juanjuan, Zhang, Kai, Gu, Feifei, Hu, Yue, Liu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193848/ https://www.ncbi.nlm.nih.gov/pubmed/34122500 http://dx.doi.org/10.3389/fgene.2021.619821 |
Ejemplares similares
-
The Efficacy of First-Generation EGFR-TKI Combined With Brain
Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With
Brain Metastases and EGFR Sensitive Mutations: A Retrospective
study
por: Liu, Yuting, et al.
Publicado: (2021) -
Integrated Analysis of MATH-Based Subtypes Reveals a Novel Screening Strategy for Early-Stage Lung Adenocarcinoma
por: Li, Chang, et al.
Publicado: (2022) -
Phenotypic and clinical characterization of low density neutrophils in patients with advanced lung adenocarcinoma
por: Liu, Yangyang, et al.
Publicado: (2017) -
Application of metabolomics by UHPLC-MS/MS in diagnostics and biomarker discovery of non-small cell lung cancer
por: Liu, Yuting, et al.
Publicado: (2019) -
Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1
por: Wu, Di, et al.
Publicado: (2020)